共 334 条
- [1] Li S(2018)Diffuse large B-cell lymphoma Pathology 50 74-87
- [2] Young KH(2004)Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray Blood 103 275-282
- [3] Medeiros LJ(2002)The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma N Engl J Med 346 1937-1947
- [4] Hans CP(2013)PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies Clin Cancer Res 19 3462-3473
- [5] Weisenburger DD(2015)Several immune escape patterns in non-Hodgkin’s lymphomas Oncoimmunology 4 e1026530-2201
- [6] Greiner TC(2015)Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma Blood 126 2193-44975
- [7] Gascoyne RD(2017)Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies Oncotarget 8 44960-3034
- [8] Delabie J(2016)Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas Blood 127 3026-872
- [9] Ott G(2016)PD-L1 expression identifies high risk diffuse large B-cell lymphoma and is associated with several genomic markers Blood 128 153--220
- [10] Muller-Hermelink HK(2015)EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment Blood 126 863-3277